According to court documents, the father of Emilie Kiser's 3-year-old son was at home with their kids while she was out when ...

J&J reported second quarter earnings Tuesday. The company is under scrutiny by investors as it faces drug patent cliffs.

J&J’s strong second quarter comes a week after President Donald Trump told reporters in a cabinet meeting he would impose ...

Johnson & Johnson on Wednesday reported second quarter results that topped estimates and the company lifted its full-year outlook.

If you look at the history of the S&P 500 ( ^GSPC -0.40%) index, dividend stocks have played a significant role in ...

Plus, Adelita Grijalva wins the Democratic primary in the race for a House seat in Arizona. The seat was left vacant by her ...

House Speaker Mike Johnson urged Attorney General Pam Bondi to "come forward and explain" the administration's handling of ...

J&J boosted its annual outlook, after posting better-than-expected quarterly profit and sales. Shares rose over 1% in ...

By Michael Erman (Reuters) -Johnson & Johnson raised its full-year sales forecast on Wednesday after beating estimates for second-quarter profit on strong demand for its cancer drug, Darzalex, and ...

Johnson & Johnson beat Wall Street’s quarterly sales expectations and raised its full-year outlook, a show of confidence as the pharmaceutical industry faces the dual threats of tariffs and a ...

Report is The Hill’s a.m. newsletter. Subscribe here or using the box below: In today’s issue: ▪ Epstein uproar splits GOP ▪ What to expect at Hill Nation Summit ▪ The Bidens ...